Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia

Local production of pharmaceuticals plays a vital role in maintaining resilience of national healthcare systems, especially when it comes to facilitating access to needed medicines and decreasing exposure to imports and international supply chains. Pharma is a research-intensive industry and the systemic lack of governance and support to R&D activities in this sector, among other host of related issues such as unsupportive regulatory regimes and human resources capacity limitations, is one of the major impediments to the diversifying of locally produced pharmaceuticals portfolio. In this review, an overview of the current pharmaceutical production system in Saudi Arabia, its major challenges, and proposed remedies to address them will be highlighted.     

基于清晰集定性比较分析的地方政府县域医共体创新实践影响因素及其组合路径分析

背景地方政府创新的影响因素分析一直是地方治理创新研究的重要议题。目的探究影响地方政府县域医共体创新实践的因素，并分析其组合路径。方法于2021年3月，以中国医院协会医共体分会举办的第二届"寻找县域医共体实践价值案例"评选活动的初选结果为案例源，将"政策创新类型"作为结果变量（中央主导型创新/地方回应型创新=0，地方自发型创新=1），以经济发展水平、行政层级、地理区位、问题属性及平台作为条件变量，采用清晰集定性比较分析（csQCA）法，通过必要条件分析、充分条件组合分析，探究影响地方政府县域医共体创新实践的因素并构建地方政府县域医共体创新实践的影响路径模型。结果5个条件变量一致性均<0.9，即经济发展水平、行政层级、地理区位、问题属性及平台均不是地方自发型创新的必要条件。条件变量组合分析（基于中间解）结果显示，共得到5组前因条件组合，分别为：经济发展水平*~地理区位*平台，行政层级*~地理区位*平台，经济发展水平*问题属性*平台，~经济发展水平*地理区位*~问题属性*平台，经济发展水平*行政层级*地理区位*问题属性（*表示"且"，~表示"非"）。5组前因条件组合一致性指标均为1，原始覆盖率为0.14~0.43，净覆盖率为0.14~0.43，总体覆盖率为1。地方政府县域医共体创新实践主要呈现出两类模式，即平台型创新模式和动机型创新模式。结论若要实现高水平的医共体创新实践，应该关注政策与当地经济发展水平之间的强相关性，激活地方政府的主动创新意愿，以及加强对县域医共体的平台支持。本研究对于理解地方政府县域医共体创新实践的机理乃至地方政府创新都具有一定价值。     

探讨创新管理理念下医院管理的方法与实践

目的分析创新管理理念下医院管理的方法与实践工作。方法对创新管理理念组和常规管理组进行回顾性分析,比较两组的医疗服务效果。结果创新管理理念组在医疗质量、医技水平、服务水平、就医环境、医风医德的总体评分以及医护人员满意度上均优于常规管理组。结论切合医院实际创新的内部管理理念,能够提升医院的服务质量,提高医院的竞争力。     

The application of technology acceptance and diffusion of innovation models in healthcare informatics

There have been many attempts to apply previously developed models of technology acceptance and the diffusion of innovations; however the models have weaknesses in predicting the behaviour of individuals and organisations, particularly within the complex health domain. The insights recent work on these models offer is relevant to health informatics development and innovation and need to be considered in the development of organisational strategies. This paper analyses the merits of several relevant models and explores their potential significance for the success or otherwise of health related Information Technology projects, highlighting their weaknesses in relation to the lack of differentiation between technological and human factors which limit their applicability in practice.     

Androgen receptor-independent prostate cancer: an emerging clinical entity

Androgen deprivation therapy remains the backbone of prostate cancer treatment given its pivotal role in the pathogenesis of prostate cancer. The growing knowledge of androgen receptor-independent (i.e. AR-null) prostate cancer cells, however, might advance the treatment paradigm of prostate cancer. Here, we examined the results of two recent studies, published in Cancer Cell by Bluemn and Shukla et al., and their impact in the future management of castration-resistant prostate cancer.